Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Lilly identifies new JAK1 inhibitors

Feb. 6, 2018

Fibrocell Science submits IND for gene therapy candidate for scleroderma

Feb. 6, 2018

Asahi Kasei launches Kevzara in Japan

Feb. 5, 2018

Anika Therapeutics collaborates with University of Liverpool on MSC therapy for osteoarthritis

Feb. 2, 2018

Pfizer enrolling patients in phase II study of PF-06823859 in moderate to severe dermatomyositis

Feb. 2, 2018

AstraZeneca initiates phase IIa study of AZD-9567 in rheumatoid arthritis

Feb. 1, 2018

European Commission grants approval to Taltz for active psoriatic arthritis

Jan. 25, 2018

The University of Kentucky patents prostaglandin E synthase inhibitors

Jan. 22, 2018

Etanercept biosimilar approved in Japan

Jan. 22, 2018

FDA accepts Sandoz's BLA for adalimumab biosimilar

Jan. 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...